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Highlights 
 Analysis of complete capsule loci in all 18 serovars of A. pleuropneumoniae 
 Novel insights into evolution of capsule loci in A. pleuropneumoniae 
 Development of two mPCRs for comprehensive capsule typing  
 
 
Abstract 
 
Problems with serological cross-reactivity have led to development of a 
number of PCRs (individual and multiplex) for molecular typing of 
Actinobacillus pleuropneumoniae, the causative agent of porcine 
pleuropneumonia. Most of these assays were developed for detection of 
specific amplicons within capsule biosynthetic genes before the availability of 
complete sequences for the different serovars. Here we describe comparative 
analysis of the complete capsular loci for all 18 serovars of A. 
pleuropneumoniae, and development of two multiplex PCRs for 
comprehensive capsule typing of this important pig pathogen. 
Keywords: diagnostic; mPCR; capsule typing; A. pleuropneumoniae serovars 
 
1. Introduction 
 Pleuropneumonia is an economically important disease causing 
considerable losses in the worldwide swine industry (Sassu et al., 2017). The 
causative agent, Actinobacillus pleuropneumoniae, can be differentiated into 2 
biovars based on the requirement for nicotinamide adenine dinucleotide 
(NAD-dependent biovar 1; NAD-independent biovar 2); and subsequently into 
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18 serovars based on surface polysaccharides, mainly capsule (Bossé et al., 
2018). The ability to discriminate between serovars is advantageous, as there 
are differences in geographical distribution that are not static (Gottschalk, 
2015; Sassu et al., 2017), as well as differences in levels of virulence 
(Klitgaard et al., 2010). Thus, accurate typing is essential for diagnosis and for 
tracking the emergence of serovars rarely, or not previously, reported within a 
geographical region. 
 
Although a number of serological tests are available for typing A. 
pleuropneumoniae isolates [see (Gottschalk, 2015) for a recent review], the 
need for high quality reference antisera limit the number of laboratories able 
to perform diagnostics, and even then, problems with cross reactivity between 
certain serovars are unavoidable. Increasingly, laboratories are using 
molecular typing methods to more accurately and reproducibly identify A. 
pleuropneumoniae isolates (Gottschalk, 2015; Sassu et al., 2017). PCRs have 
been developed for detection of specific CPS genes in most of the currently 
recognized 18 serovars (except 4, 9, 11, 13 and 14), either individually or in 
multiplex reactions for detection of predominant serovars in a given 
geographical region (Angen et al., 2008; Bossé et al., 2014; 2017; 2018; Ito 
and Sueyoshi, 2015; Jessing et al., 2003; Schuchert et al., 2004; Turni et al., 
2014). Some of these PCR assays were developed prior to the availability of 
whole genome sequences (wgs), and were based on (sometimes incomplete) 
sequences of the CPS biosynthetic loci.  
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The aim of this study was to comprehensively analyze the complete 
CPS loci for all known serovars of A. pleuropneumoniae, and to develop 
multiplex PCRs capable of their specific identification.  
 
2. Materials and Methods 
2.1 A. pleuropneumoniae isolates used in this study 
 All sequences used in this study are shown in Table 1, with accession 
numbers shown for previously published whole genomes and for the full CPS 
loci of serovars lacking full genome sequences in Genbank. In this study, wgs 
data was generated for the reference strains of serovars 13 (N273), 14 
(3906), and 15 (HS143), and for two isolates of K2:O7 (7317/84 and 
9712534), as previously described (Bossé et al., 2018). The regions of whole 
genome sequences containing the complete CPS loci (export and biosynthetic 
genes) were identified initially by using tBLASTn (http://blast.ncbi.nlm.nih.gov 
/Blast.cgi) to identify the cpxD gene (accession AIA09380) common to all A. 
pleuropneumoniae serovars. The complete CPS loci, found between the 
genes modF and ydeN in all serovars, were extracted for further analysis 
using BLASTn and BLASTx. Multiple sequence alignments were performed 
using ClustalW, and a schematic representation of each locus was generated 
using Gene Graphics (Harrison et al., 2017), with a Neigbour-Joining tree 
constructed using the Tamura-Nei algorithm with 1000 bootstraps (Figure 1).  
The complete capsule loci (with flanking sequences modF and ydeN) 
for the reference strains of serovars 13-16, and for the two isolates of K2:O7 
(7317/84 and 9712534) have been deposited in GenBank under accession 
numbers MG868947 to MG868952. 
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 2.2 Diagnostic PCRs 
 The primer pairs used in APP-mPCR1 for specific detection of serovars 
1-12 and 15, along with the common apxIV amplicon used in previous mPCRs 
for species level detection of A. pleuropneumoniae, are shown in Table 2. 
Some of the primer pairs were used in our previous mPCR (Bossé et al., 
2014), whereas new pairs were designed, either to improve specificity for 
previously tested serovars (e.g. 3, 6, and 8), or for serovars not previously 
included in our mPCR. All primers were designed to amplify sequences 
specific to the relevant serovar, with generation of amplicons of different sizes 
to allow sufficient separation of all amplicons by gel electrophoresis in 1.5% 
agarose. The specificity of all primers were initially tested in individual PCRs 
using genomic DNA from the homologous serovar reference strains, followed 
by incorporation of all primers into multiplex format, using the Qiagen 
Multiplex PCR Plus kit as previously described (Bossé et al., 2014). APP-
mPCR1 was then tested with all of the 18 A. pleuropneumoniae serovar 
reference strains (i.e. 4074T, 1536, S1421, M62, K17, L20, Femø, WF83, 405, 
CVJ13261, D13039, 56153, 8328, N-273, 3906, HS143, A-85/14, 16287-1, 
and 7311555, respectively), as well as a set of clinical isolates comprising 2-5 
isolates of each of the 18 A. pleuropneumoniae serovars, and 31 other 
porcine-associated bacterial species, used in previous studies (Bossé et al., 
2017; 2018). Furthermore, as our previous mPCR (Bossé et al., 2014) was 
found to detect both serovar 2 and 8 amplicons using DNA from the K2:O7 
isolates 7317/84 and 9712534, we specifically compared our new APP-
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mPCR1 to our previous mPCR for detection of specific amplicons from these 
two isolates. 
The primer pairs used in APP-mPCR2 for specific detection of A. 
pleuropneumoniae serovars 13-14, and 16-18, along with the species specific 
apxIV amplicon and the full length nadV gene found in biovar 2 isolates, are 
shown in Table 3. The specificity of these primers was evaluated as for the 
mPCR1 primers above. 
 
3. Results and Discussion  
 Initial analyses of the CPS loci in publically available genomes of A. 
pleuropneumoniae (Table 1) revealed that sequences previously deposited in 
Genbank as Shope 4074 (accession AACK00000000) and N273 (accession 
ADOM00000000) appear to be incorrect, having CPS loci matching serovars 
5 and 7, respectively. The serovar 1 CPS locus is found in the genome of 
Shope 4074 (accession ADOD00000000) as well as in the recently closed 
genome of strain KL 16 (accession CP022715) (Xu et al., 2010; Park et al., 
2017). The correct serovar 13 CPS locus (accession number MG868947) was 
identified in the draft genome of N273 that was generated as part of this 
study, and although similar to the serovar 7 locus (Figure 1), the cps13D gene 
encodes a predicted protein that shares only 43% identity with that of the 
Cps7D CDP-glycerol-glycerophosphate glycerophosphotransferase protein. 
Furthermore, the cps13E gene shows no homology to any other sequence in 
Genbank at the nucleotide level, and the encoded protein shares limited 
identity (<35%) with hypothetical proteins from various Gram-positive species 
(e.g. accession number WP_010632822).  
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Although sequences for the CPS loci of serovars 14, 15, and 16 have 
previously been deposited in Genbank (accession numbers AB810251, 
AB701753, KX907602), we have extended these sequences (accession 
numbers MG868948, MG868949, MG868950) to encompass the complete 
CPS loci in order to allow a more thorough comparison with the other 
serovars. Additionally, we have generated draft genomes of two serovar 
K2:07 isolates in order to compare their CPS loci (accession numbers 
MG868951 and MG868952) to those in the two published serovar 2 genomes 
(accession numbers ADXN00000000 and ADOE00000000) (Xu et al., 2010; 
Zhan et al., 2010). Although the genes in the K2:O7 CPS loci encode the 
same proteins as in the serovar 2 CPS loci, there are differences at the 
nucleotide level that explain amplification of both serovar 2 and 8 amplicons 
for K2:O7 isolates using our previously designed mPCR (Bossé et al., 2014). 
In that assay, the serovar 8 primers were designed to amplify an 1106 bp 
fragment spanning parts of the cpsAB genes, and were specific when tested 
using a large number of clinical isolates, including 45 serovar 2 and 115 
serovar 8 isolates (Bossé et al., 2014), however no K2:O7 isolates were 
tested at that time. Furthermore, we recently found that these serovar 8 
primers also produced amplicons from some, but not all, serovar 17 isolates 
(Bossé et al., 2018). Before redesigning new primers for specific detection of 
serovar 8, as well as designing primers for detection of serovars 4, 9, 11, and 
14 (for which there are currently no molecular diagnostics), we thoroughly 
analysed the complete CPS loci of all known A. pleuropneumoniae serovars. 
In each serovar, the complete CPS locus is found between the genes 
modF, encoding a putative molybdenum transport ATP-binding protein, and 
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ydeN, encoding a predicted serine hydrolase (Figure 1). The CPS export 
genes, cpxABCD, are transcribed divergently from the CPS biosynthetic 
genes for all but serovar 15, where the export genes are immediately 
downstream of the biosynthetic genes, in the same orientation (Ito and 
Sueyoshi, 2014). The organization of the CPS export genes next to the 
biosynthetic genes is similar in other members of the Pasteurellaceae as well 
as in other Gram-negative bacteria, such as Escherichia coli and Neisseria 
meningitidis, suggesting a common molecular origin for these loci (Boulnoisl 
and Jann, 1989; Frosch et al., 1991; Lâm et al., 2011). In many of these 
bacteria, a third region containing genes involved in post-polymerization 
modifications/transport is found on the other side of the biosynthetic locus, 
such that the central biosynthetic genes (region II) are variable, whilst the 
flanking regions I and III are constant in a given species (Boulnoisl and Jann, 
1989; Frosch et al., 1991). In A. pleuropneumoniae, only regions I and II are 
contiguous, whereas genes encoding proteins sharing 63% and 66% identity, 
respectively, with HcsA and HcsB (encoded by region III of Haemophilus 
influenzae) are found elsewhere in the chromosome (accession numbers 
WP_039709373 and WP_005610771).  
The CPS biosynthetic loci of the different A. pleuropneumoniae 
serovars can be grouped into four types (Figure 1), with common core genes 
identified in each for types I-III, and type IV only found in serovar 16 (Xu et al., 
2010; Bossé et al., 2017). The most common are the type I loci, found in 
serovars 2, 3, 6, 7, 8, 9, 11, 13, and 17 (Xu et al., 2010; Bosse et al., 2018), 
which produce teichoic acid-type polymers with phosphodiester linkages 
joining repeating glycosyl-glycitol units (Perry et al., 1990; MacLean et al., 
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2004). The core cpsABC genes of the type I loci are well conserved, sharing a 
minimum of 88% identity, and encode a CDP-glycerol 
glycerophosphotransferase, a glycerol-3-phosphate cytidylyltransferase, and 
a protein of unknown function, respectively. Although less well conserved, the 
type I cpsD genes all encode proteins with a glycosyl transferase domain 
(pfam04464) and a glycosyl transferase group 1 domain (either pfam00534 or 
pfam13692), that are, along with the products of the cpsABC genes, predicted 
to be involved in synthesis of the teichoic acid-type polymers characteristic of 
type I CPSs. In serovar 3, the cpsD gene has been split into two open reading 
frames due to an internal stop codon. It is not known if the second orf (cpsD’) 
is translated, as there is no obvious ribosomal binding site preceding the start. 
The sequences spanning cpsD and cpsD’ in serovar 3 share 86% identity with 
the cpsD genes found in serovars 9 and 11; the cpsD gene from serovar 2 
shares 76% identity with that of serovar 7, but only 56% with that of serovar 
13; and the cpsD gene from serovar 8 shares 96% and 98% identity with 
those from serovars 6 and 17, respectively. Serovars 6, 8 and 17 further 
share a common cpsE gene (84% identity for the serovar 6 gene compared to 
the serovar 8 and 17 genes, which share 99% identity). Additionally, the last 
gene of the serovar 8 locus (cps8H) shares 90% identity with the final 911 
bases of the 1548 bp cps17F gene, as previously noted (2).  
Type II loci are found in serovars 1, 4, 12, 14, 15, and 18 (Xu et al., 
2010; Ito and Sueyoshi, 2014; Ito, 2015; Bossé et al., 2018), and produce 
repeating oligosaccharide polymers with phosphate linkages, as shown for 
serovars 1, 4, 12, and 15 (Perry et al., 1990; 2011). The conserved cpsA 
genes in these loci (99% identical for all but cps15A, which shares only 65% 
AC
CE
PT
ED
 M
AN
US
CR
IPT
identity) all encode a capsular polysaccharide phosphotransferase which 
likely mediates the phosphate linkages characteristic of type II CPSs. 
Serovars 5 and 10 have type III loci and produce glycosidically linked sugar 
polymers (Perry et al., 1990), with the common core genes (kdsA, kdsB and 
kpsF, found at the 3’ end of theses loci) encoding 2-dehydro-3-
deoxyphosphooctonate aldolase, 3-deoxy-manno-octulosonate 
cytidylyltransferase, and arabinose 5-phosphate isomerase, respectively. The 
serovar 16 CPS locus (type IV) is entirely unique, and the structure of this 
CPS has not yet been determined.  
 All of the type II loci have a 114 bp orf followed by a partial lysA gene 
(of varying length) upstream of ydeN (Figure 1) that are not likely involved in 
CPS synthesis. These sequences are also found in the type I loci of serovars 
8 and 17; whereas all the remaining serovars with type I, III and IV loci, have 
a 552-555 bp gene encoding a hypothetical protein of unknown function 
(though again, not likely involved in CPS synthesis) immediately upstream of 
ydeN, except for the serovar 6 reference strain Femø, where ydeN 
immediately follows the last cps gene (Figure 1). These genes preceding 
ydeN delineate the 3’ boundaries of the different CPS biosynthetic loci in A. 
pleuropneumoniae, and give an indication of possible evolutionary origins.  
There are terminal inverted repeats (IRs) of 35-46 bp, containing a 
central IR sequence, flanking all of the A. pleuropneumoniae capsule loci that 
end with the 114 bp orf and partial lysA gene. Along with the atypically low GC 
content of the A. pleuropneumoniae CPS loci (especially the biosynthetic 
genes that have GC contents around 10% lower than respective genomes), 
the presence of IRs at the boundaries are indicative of the CPS loci being 
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insertion elements acquired by horizontal transfer (Darmon and Leach, 2014). 
All A. pleuropneumoniae serovars, regardless of capsule type, have at least 
part of the 46 bp sequence 
TAAAGGAAATCCCCc/tTCTTTAGTAAAGAGGGg/aTTAGGGGAGATTTG 
(lower case letters indicating differences in some serovars at these bases; IR 
sequence underlined) downstream of modF, along with an almost perfect 
repeat of the central IR (CCCCTCTTTGCTAAAGAGGGG) close to the 3’ end 
of cpxA, suggesting it may be a rho-independent terminator for this gene. In 
serovars 1, 9, 11, and 18, there may have been recombination between the 
two copies of the IR such that only a single copy is found, with 35 of the 46 bp 
sequence conserved 
(TAAAGGAAATCCCCCTCTTTAGTAAAGAGGGGGGAT) upstream of cpxA 
in these serovars. An almost identical, but inverted, 46 bp sequence 
(CAAATCTCCCCTATCc/aCCTCTTTACTAAAGAGGGGg/aATTTCCTTTA) is 
found downstream of the final CPS biosynthetic gene in all loci that are 
followed by the 114 bp orf and partial lysA gene, whereas in serovars with 
CPS loci followed by a 552-555 bp gene, no evidence of this sequence is 
seen. These data suggest that, in A. pleuropneumoniae, a type II CPS locus 
was the first to be acquired by horizontal transfer, with subsequent 
diversification of the other biosynthetic loci via gene deletion and/or 
acquisition of other capsule genes by horizontal transfer and homologous 
recombination via conserved flanking sequences.  
The A. pleuropneumoniae serovar 14 type II CPS locus was previously 
shown to be almost identical to that found in Actinobacillus suis K1 strains 
such as ATCC 33415 (accession CP009159) (Ito, 2015). As in A. 
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pleuropneumoniae, the CPS export genes in A. suis are downstream of 
modF. The biosynthetic genes in A. suis are followed by the same 114 bp orf 
as in the A. pleuropneumoniae type II CPS loci. However, in A. suis, this orf is 
followed by a complete lysA gene (1251 bp), and three further genes (gst, 
hemN, and a 600 bp gene encoding a putative nucleoside-diphosphate-
sugarepimerase), prior to the ydeN gene. This variation in gene arrangement 
allows differentiation of these two species by diagnostic PCR (see below). In 
A. pleuropneumoniae, the five genes found upstream of ydeN in A. suis are 
found elsewhere in the genome (downstream of frdD). These data suggest 
that A. pleuropneumoniae serovar 14 may have acquired the A. suis CPS 
locus en bloc, with the resulting duplication of the 114 bp orf and part of the 
lysA gene. The other A. pleuropneumoniae serovars with type II CPS loci 
have reduced complexity of CPS genes compared to serovar 14, with only the 
cpsA gene conserved, and the other genes specific for each serovar. 
Previously, the most complex mPCR for typing of A. pleuropneumoniae 
contained primers for detection of serovars 1-3, 5-8, 10 and 12, with the 
addition of primers for apxIV to allow detection of other serovars not included 
(Bossé et al., 2014). Now, with a total of 18 serovars, plus the species-specific 
apxIV amplicon, it was technically challenging to accurately resolve all of the 
products in a single mPCR. We therefore developed two mPCRs (APP 
mPCR1 and APP mPCR2), with the first capable of detecting serovars 1-12 
and 15, and the second for detection of serovars 13, 14, and 16-18. All primer 
sequences for APP mPCR1 and APP mPCR2 are shown in Tables 2 and 3. 
To reduce the risk of non-specific priming, all primers were designed to have 
a Tm of 58-63°C. 
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We kept some of the primer pairs from our previous 9-serovar mPCR 
(Bossé et al., 2014), including those for detection of serovars 1, 2, 5, 10 and 
12, but revised our selection of primers for serovars 3, 6, 7, and 8 in order to 
target the more serovar-specific genes towards the end of these biosynthetic 
loci. To maintain good size separation of products in the revised mPCR, the 
new serovar 3, 6, 7, and 8 primers were designed to produce similar sized 
amplicons as the previous primer pairs. To this new mPCR (APP mPCR1), we 
added primers for detection of a 1595 bp fragment spanning the cpsBC genes 
of serovar 15. As there have not previously been diagnostic PCRs for the 
capsule genes of serovars 4, 9, or 11, we analyzed their biosynthetic loci in 
order to find appropriate specific priming sites. For serovar 4, primers were 
designed to amplify a unique 204 bp sequence at the 3’ end of the cpsB gene. 
Alignments of the complete CPS loci (including the export genes and flanking 
sequences to modF and the 555 bp gene) of the serovar 9 and 11 reference 
strains revealed the only difference is a single base deletion in the final cps 
gene in serovar 11, such that the reading frame ahead of the deletion shifted 
to use an alternate start codon. In serovar 9, the cpsF gene is 1146 bp, and 
that of serovar 11 is 1242 bp. The encoded proteins have the same C-
terminal 349 AAs. It is possible that the altered N-terminal AAs are 
responsible for the slight differences in the CPS structures of these serovars 
reported by Perry et al. (Perry et al., 1990). These serovars also share an 
almost identical LPS O-antigen (Perry et al., 1990), and serologically, it is 
difficult to distinguish serovars 9 and 11. As these serovars also produce the 
same complement of Apx toxins (Frey, 1995), there may be little value in 
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distinguishing them. The primers we have designed for combined detection of 
serovars 9/11 amplify a 2105 bp fragment spanning their cpsEF genes.  
The new APP-mPCR1 detects amplicons from serovars 1-12 and 15, 
ranging in size from 204 to 2105 bp, plus the 418 bp apxIV amplicon as an 
internal control for detection of all A. pleuropneumoniae serovars, as shown 
for each of the the A. pleuropneumoniae reference strains tested (Figure 2). 
The specificity of this mPCR was further demonstrated using DNA prepared 
from our collection of clinical A. pleuropneumoniae isolates, other 
Actinobacillus species, other Pasteurellaceae, and other major pathogens of 
pigs, in addition to virtual PCRs using all available genomes of the species 
investigated, where available, as previously described (Bossé et al., 2017). All 
A. pleuropneumoniae isolates produced the 418 bp apxIV amplicon in addition 
to the appropriate serovar-specific bands for each of serovars 1-12 and 15. 
Furthermore, DNA from the K2:O7 isolates 7317/84 and 9712534, that 
produced amplicons for both serovars 2 and 8 (and apxIV) with our previous 
9-serovar mPCR, produced only the serovar 2 and apxIV amplicons in the 
new APP-mPCR1 (Figure 3).  All non-A. pleuropneumoniae isolates were 
negative for all amplicons (data not shown). 
For development of the new APP-mPCR2, we combined the same 
apxIV primers used in APP-mPCR1 with our previously designed primers for 
detection of the most recently identified serovars 16, 17 and 18 (212, 302 and 
514 bp amplicons, respectively) (Bossé et al., 2017; 2018). To this mPCR, we 
added primers for detection of serovars 13 and 14. As mentioned at the 
beginning of this discussion, the serovar 13 CPS locus contains a unique 
gene, cps13E, not seen in any other sequenced bacterium, so we designed 
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primers to detect a 665 bp fragment of this gene. The analysis of the serovar 
14 CPS locus, as discussed above, indicated that primers designed to detect 
any of the cps genes would also detect the related swine pathogen, A. suis. 
However, by designing primers to amplify a 1911 bp fragment from cps14G to 
ydeN, it is possible to differentiate this sequence from A. suis, where the ydeN 
gene is almost 6 kb downstream of the final cps gene. Since serovars 13, 14, 
and 17 are predominantly biovar 2, with biovar 1 isolates also reported for 
serovars 13 and 17 (Bosse et al., 2018; Gottschalk, 2015; Sassu et al., 2017), 
we added primers for detection of a 1339 bp fragment of the nadV gene, 
which confers NAD-independence. 
  Thus, the new APP-mPCR2 detects amplicons for apxIV, nadV, and 
serovars 13-14 and 16-18, ranging in size from 212 to 1339 bp. Specific 
detection of these amplicons was demonstrated using DNA from each of the 
the A. pleuropneumoniae reference strains (Figure 4), as well as the same set 
of samples used above for validation of the APP-mPCR1. Again, all non-A. 
pleuropneumoniae isolates were negative for all amplicons (data not shown). 
Comparison of biovar 1 and 2 isolates of serovar 17 show that the inclusion of 
the nadV primers in this mPCR facilitate differentiation of these isolates 
(Figure 4). Lack of detection of a nadV amplicon in NAD-independent non-A. 
pleuropneumoniae isolates, such as A. suis, indicates that the primer 
sequences used are specific for the A. pleuropneumoniae nadV gene. 
 In conclusion, we have developed two mPCRs, APP-mPCR1 and APP-
mPCR2, for specific detection of all 18 known serovars of A. 
pleuropneumoniae. Inclusion of primers for detection of apxIV in both mPCRs 
provides an internal control for species-specific detection of all A. 
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pleuropneumoniae serovars. In general, we would recommend testing 
samples with APP-mPCR1 first. Any samples producing a positive apxIV 
band, but none of the amplicons for serovars 1-12 or 15, should then be 
tested using APP-mPCR2.   
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Figure 1. Schematic comparison of the complete capsule loci of A. 
pleuropneumoniae serovars 1-18 and K2:O7. The capsule loci are arranged 
according to phylogenetic similarity, as indicated by the tree on the left, and 
are clustered into their respective CPS types (I-IV) as indicated by the labeled 
brackets. All loci are flanked by the modF gene at the start (white arrow in 
shaded grey box; note an internal stop codon is present in the serovar 6 
modF sequence), and ydeN at the end, preceded either the by the 552-555 bp 
hypothetical gene or the 114 bp hypothetical and partial lysA genes (white 
arrow, preceded by either mauve or brown arrows, respectively, in shaded 
grey box). The capsule export genes, cpxABCD, are indicated as reverse 
oriented arrows shaded black to light grey, respectively. The genes of the 
respective serovar CPS biosynthetic loci are named as follows: 
cps2ABCDEFG (for both K2:O7 and serovar 2); cps7ABCDE, cps13ABCDE, 
cps3ABCDD’EF, cps11ABCDEF, cps9ABCDEF, cps6ABCDEFG, 
cps17ABCDEF, cps8ABCDEFGH, cps16ABCDEF, cps10ABCD kdsAB kpsF, 
cps5ABC kdsAB kpsF, cps15ABC, cps4ABC, cps12ABB’, cps18ABC, 
cps14AB1B2B3CDEFG, CPS1ABCD. The core cpsABC genes conserved in all 
of type I CPS loci are indicated as the dark, medium, and light blue arrows, 
respectively (note the extra gene at the start of the serovar 7 biosynthetic 
locus, shown as a striped arrow, indicates the ISApl1 insertion present in the 
AP76 strain, and is not part of the biosynthetic locus). The cpsD genes in the 
type I loci are indicated in different shades of teal, according to similarity 
greater than 50% identity (note in serovar 3, an internal stop codon has 
resulted in two orfs, cps3D and cps3D’). In serovars 6, 17 and 8, the cpsE 
genes share >80% identity and are shown as bright green arrows; and the 
last gene in the serovar 8 locus, cps8H, shares 94% identity with the C-
terminal half of the serovar 17 cpsF gene, as indicated by the olive shaded 
arrows in the respective loci. The core genes in the type III CPS loci (kdsAB 
and kpsF) are indicated by the dark red, bright red, and pink arrows, 
respectively, at the ends of the serovar 5 and 10 loci. In the type II loci, the 
conserved core cpsA gene is shown as a yellow arrow. The white arrows in 
each biosynthetic locus indicate genes unique to each serovar. As expected, 
the K2:O7 CPS locus shares 96% identity across the entire sequence with 
that of serovar 2 (with nucleotide differences being mainly found in the 
cpsABC genes), and the specific cps2EFG genes found at the ends of both of 
these loci are boxed. Serovars 9 and 11 share 99% identity across their 
cpsEF genes (also shown boxed), with only a single nucleotide difference 
resulting in an alternate start codon for the cpsF gene in each locus. The 
Neighbour-Joining tree shown at the left of the figure was constructed using 
the Tamura-Nei algorithm with 1000 bootstraps, and that the width of the line 
underneath it shows a 5% nucleotide difference. 
 
 
Figure 2. Serovar-specific detection of amplicons from A. pleuropneumoniae 
serovars 1-12 and 15 by APP mPCR1. An apxIV (418-bp) amplicon is 
detected in all 18 serovar reference strains. Lane M contains molecular size 
markers (100-bp Plus DNA Ladder; Invitogen). Lanes 1 to 18 contain the 
following strains: 1, 4074T; 2, S1536; 3, S1421; 4, M62; 5, L20; 6, Femø; 7, 
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WF83; 8, 405; 9, CVJ13261; 10, D13039; 11, 56153; 12, 8329; 13, N-273; 14, 
3906; 15, HS143; 16, A-85/14; 17, 16287-1; 18, 7311555. 
 
 
 
Figure 3. Comparison of previous mPCR (8), and new APP mPCR1 for 
detection of A. pleuropneumoniae serovars 2, 8 and K2:O7. The K2:O7 
isolates (7317/84 in lane 1; 9712534 in lane 2) produced amplicons indicative 
of both serovars 2 and 8 with the previous mPCR (A), but only the correct 
serovar 2 amplicon with APP mPCR1 (B). Lanes 3 and 4 contain serovar 2 
strain S1536 and serovar 8 strain 405, respectively. Lane M contains 
molecular size markers (100-bp Plus DNA Ladder; Invitogen). 
 
 
Figure 4. Serovar-specific detection of amplicons from A. pleuropneumoniae 
serovars 13-14 and 16-18 by APP mPCR2. An apxIV (418-bp) amplicon is 
detected in all 18 serovar reference strains, and an additional 1339 bp nadV 
amplicon is detected only in the biovar 2 strains. Lane M contains molecular 
size markers (100-bp Plus DNA Ladder; Invitogen). Lanes 1 to 18 contain the 
following strains: 1, 4074T; 2, S1536; 3, S1421; 4, M62; 5, L20; 6, Femø; 7, 
WF83; 8, 405; 9, CVJ13261; 10, D13039; 11, 56153; 12, 8329; 13, N-273; 14, 
3906; 15, HS143; 16, A-85/14; 17, 16287-1; 18, 7311555. Lane 19 contains 
the biovar 2 serovar 17 isolate, 14-022, and Lane 20 contains A. suis CCM 
5586T. 
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Table 1. Accession numbers for APP sequences used in this study 
 
Serovar Strain Accession Reference 
1 4074a ADOD00000000  (Xu et al., 2010) 
1 KL 16 CP022715 (Bosse et al., 
2006; Gottschalk, 
2015; Sassu et 
al., 2017) 
2 4222 ADXN00000000 (Zhan et al., 
2010) 
2 S1536 ADOE00000000  (Xu et al., 2010) 
K2:07 7317/84 MG868951 This study 
K2:07 9712534 MG868952 This study 
3 JL03 CP000687 (Xu et al., 2008) 
4 M62 ADOF00000000  (Xu et al., 2010) 
5b L20 CP000569 (Foote et al., 
2008) 
6 Femø ADOG00000000  (Xu et al., 2010) 
7 AP76 CP001091  
7 S8 ALYN00000000 (Li et al., 2012) 
8 MIDG2331 LN908249 (Bossé et al., 
2016) 
9 CVJ13261 ADOI00000000  (Xu et al., 2010) 
10 D13039 ADOJ00000000 (Xu et al., 2010) 
11 56153 ADOK00000000 (Xu et al., 2010) 
12 1096 ADOL00000000 (Xu et al., 2010) 
13 N273 MG868947 This study 
14 3906  MG868948 This study 
15 HS143 MG868949 This study 
16 A-85/14  MG868950 This study 
17 16287-1 MG780416 (Bosse et al., 
2006) 
18 7311555 MG780423 (Bosse et al., 
2006) 
 
a The genome listed as serovar 1 str. 4074, accession number 
AACK00000000, is actually a serovar 5 isolate. 
The genome listed as serovar 13 str. N273, accession number 
ADOM00000000, is actually a serovar 7 isolate. 
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Table 2. APP-mPCR1 primers for detection of serovars 1-12 and 15. 
Primer 
name 
Sequence Target 
genea 
Amplicon 
size 
Reference or 
source 
AP1F CTGGAGTAATTACGGCGACTATTCC cps1B 959 (Bossé et al., 
2014) AP1R AGGAGAAGCTAGTAGTACTTGCATTTTC cps1B 
AP2F GAGTGTGATGATGATGCTCTGGTTC cps2E 247 (Bossé et al., 
2014) AP2R TACCAATAACTGTTGCAACTAACGC cps2E 
AP3F TTGTAGAGCCCGCCAGATTTACG cps3F 500 This study 
AP3R CATTCGCACCAGCAATCACC cps3F 
AP4F CAGCATGGGTTTGGTCCTGTTG cps4B 204 This study 
AP4R GGCTTTCTCCGTGTATGAATAAAGTG cps4B 
AP5F AGCCACAAGACCCGAATGGTATAATG cps5B 825 (Bossé et al., 
2014) AP5R CCATCAAATGCAGCTTCAAGGAGC cps5B 
AP6F TGACTGGCTTCGTGAAAATGAG cps6F 718 This study 
AP6R GTCTGAAGTTTTATTCGCAGCTCC cps6F 
AP7F TTGGAATGGATTCATGATTGGGC cps7E 601 (Bossé et al., 
2014) AP7R CGGAAATGGCCTATTGAAAAACG cps7E 
AP8F ACATCCAAGCCGTTCTCCAG cps8F 1126 This study 
AP8R CATCCATGAGCCAATGAGGG cps8G 
AP9F GTAGGACGTGGTAACATTGAGGC cps9E 2105 This study 
AP9R ACGGGTGCAATTTCTAAAGCTG cps9F 
AP10F GGTGGTGATGGAACAAGGTTATGG cps10A 183 (Bossé et al., 
2014) AP10R CTGTAATTGATGCGAAATAGTAGATTGGTGC cps10A 
AP12F TAAAGGTATTATAACGCCGGCTCT cps12A 347 (Bossé et al., 
2014) AP12R CTCCCATCTGTTGTCTAAGTAGTAG cps12A 
AP15F GCAACTTGGAGAACATGGTTAAATCAAG cps15B 1595 This study 
AP15R CAACCCTCCAATGTAAGCGAAGG cps15C 
apxIVA1 TTATCCGAACTTTGGTTTAGCC apxIV  418 (Zhou et al., 
2008) apxIVA3 CATATTTGATAAAACCATCCGTC Intergenicb 
aFor each serovar capsule locus, the biosynthetic genes are labeled alphabetically starting 
from A in each case. 
bIntergenic region immediately downstream of apxIVA. 
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Table 3. APP-mPCR2 for detection of serovars 13, 14, and 16-18. 
Primer 
name 
Sequence Target 
genea 
Amplicon 
size 
Reference 
or source 
AP13F GTTGTGTATCGAGGTTGGCATTTC cps13E 665 
 
This study 
AP13R ATGTAAAGGATCTAAGCCGTGTG cps13E 
AP14F TGCATTACGCTTATATTCTGAATGG cps14G 1911 This study 
AP14R TTGTCGATCGAGAGGGAGTAACG ydeN 
AP16F TTACTCACTTGGGCTAGGGATAG cps16C 212 (Bossé et 
al., 2017) AP16R ACCAGCAATATGATTACGCCC cps16D 
AP17F TTGTAATGGCGGTGTAATGCTAC cps17F 302 (Bosse et 
al., 2006) AP17R CATAAGTGCAGCCATCTCTTTCAG cps17F 
AP18F CGGAGTTTGGCAGCATAAAGG cps18B 514 (Bosse et 
al., 2006) AP18R CCATAATCGGTGCTCAACTAAGAATG cps18B 
nadVF CTCACTAAACAAAACTCTGCGTTC nadV 1339 This study 
nadVR TTCGGATGACAGAACTTTTACCCG nadV 
apxIVA1 TTATCCGAACTTTGGTTTAGCC apxIV  418 (Zhou et al., 
2008) apxIVA3 CATATTTGATAAAACCATCCGTC Intergenicb 
aFor each serovar capsule locus, the biosynthetic genes are labelled alphabetically starting 
from A in each case. 
bIntergenic region immediately downstream of apxIVA. 
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